Building high-performance global trials: strategies for scalable clinical development

The pharmaceutical industry faces increasing pressure to design faster, more efficient, and cost-effective clinical development programs. As sponsors in the US and the EU seek to optimize R&D pipelines, many evaluate geographical extensions that offer a combination of scientific excellence and regulatory alignment. 

In this panel discussion, Mrinal Kammili, Partha Chatterji, Siddangouda Patil, Kalavathy Elango, and Rajkumar Agarwal will discuss the technical and operational infrastructure in India that supports Phase 1 through Phase 3 trials, biometrics, and integrated clinical-to-submission capabilities.

Topics to be covered:

• Leveraging large populations to accelerate enrollment in oncology, immunology, and metabolic disease
• Maintaining global quality standards and data integrity to support international submissions
• Utilizing centralized laboratories and biostatistics to streamline the transition from clinic to submission
• Managing complex study designs and early-phase pharmacology to improve budget and resource efficiency

Monday, April 20th 2026 | 11:00 AM – 12:00 PM Eastern Time
This webinar will be available to view live and on demand.

Speakers

Mrinal Kammili, MBBS
Head of Translational and Clinical Research
Syngene International Ltd.

Partha Chatterji
Head of Clinical Trials
Syngene International Ltd.

Siddangouda Patil, PhD
Head of Human Pharmacology Unit, Medical and Scientific Writing
Syngene International Ltd.

Kalavathy Elango, MBBS, PhD
Head of Business Strategy and Process Excellence
Syngene International Ltd.

Rajkumar Agarwal
Vice President, Business Development
Syngene International Ltd.